Literature DB >> 10963723

The antioxidant drug dipyridamole spares the vitamin E and thiols in red blood cells after oxidative stress.

C Kusmic1, E Picano, C L Busceti, C Petersen, R Barsacchi.   

Abstract

OBJECTIVE: To test the antioxidant effect of therapeutic doses of dipyridamole on cellular membranes, human erythrocytes were chosen as an appropriate model to study oxidative stress induced by cumene hydroperoxide because of their high content in heme-Fe(2+).
METHODS: The oxidative stress was induced by incubation with 160 micromoll(-1) cumene hydroperoxide and expressed by three main factors: lipid peroxidation by means of kinetics of decrease in fluorescence emission of the probe incorporated in the cell membranes, vitamin E oxidation and intracellular thiol content. The concentrations of dipyridamole tested (2-20 micromoll(-1)) did not exceed pharmacological doses.
RESULTS: After 7 min of incubation at 25 degrees C with the oxidant and 20 micromoll(-1) dipyridamole thiol content was 50.1%+/-2.6 compared with 31.5%+/-2.4 in the absence of the drug. After 12 min vitamin E content was 88.3%+/-2.3 compared with 64.7%+/-3.4 of untreated cells in the absence of dipyridamole. Dipyridamole added 5 min after the oxidation reaction suppressed the fluorescence decrease for a time proportional to the drug concentration.
CONCLUSIONS: Thus, at clinically realistic doses dipyridamole shows a concentration-dependent antioxidant effect. It protects membranes from oxidation and spares the antioxidant power of erythrocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10963723     DOI: 10.1016/s0008-6363(00)00058-4

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  6 in total

1.  Separate and combined effects of heat stress and exercise on circulatory markers of oxidative stress in euhydrated humans.

Authors:  Orlando Laitano; Kameljit Kaur Kalsi; Mark Pook; Alvaro Reischak Oliveira; José González-Alonso
Journal:  Eur J Appl Physiol       Date:  2010-07-24       Impact factor: 3.078

2.  Dipyridamole reverses peripheral ischemia and induces angiogenesis in the Db/Db diabetic mouse hind-limb model by decreasing oxidative stress.

Authors:  Christopher B Pattillo; Shyamal C Bir; Billy G Branch; Eric Greber; Xinggui Shen; Sibile Pardue; Rakesh P Patel; Christopher G Kevil
Journal:  Free Radic Biol Med       Date:  2010-11-09       Impact factor: 7.376

Review 3.  Translational therapeutics of dipyridamole.

Authors:  Hyung-Hwan Kim; James K Liao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-03       Impact factor: 8.311

4.  Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients.

Authors:  Kholoud F Aliter; Rami A Al-Horani
Journal:  Curr Pharm Des       Date:  2021       Impact factor: 3.116

5.  Proton-coupled electron-transfer mechanism for the radical scavenging activity of cardiovascular drug dipyridamole.

Authors:  Abolfazl Barzegar
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

6.  Dipyridamole reduces penile apoptosis in a rat model of post-prostatectomy erectile dysfunction.

Authors:  Omer Kutlu; Ersagun Karaguzel; Ali Ertan Okatan; Ahmet Mentese; Esin Yulug; Ilke Onur Kazaz; Selcuk Kutlu; Eyup Dil; Huseyin Eren; Ahmet Alver
Journal:  Int Braz J Urol       Date:  2017 Sep-Oct       Impact factor: 1.541

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.